Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
Contact

Biomarkers for the clinical evaluation of cognitive impairment

  • Category: Published research
  • Product: NeuroQuant
  • Disease: Neurodementias, Traumatic brain injury

Biomarkers for the clinical evaluation of the cognitively impaired elderly, amyloid is not enough

Recently published in the journal Imaging in Medicine (June, 2012), Linda K. McEvoy and James B. Brewer argue that while incorporating biomarkers for assessing Alzheimer’s disease risk, including volumetric MRI done with NeuroQuant®, can help in patient prognosis, tests for amyloid, if used in isolation, have potential for harm, as amyloid tests are clinically useful only when evidence suggests progressive cognitive decline or neurodegeneration. (Imaging in Medicine, June 2012, Vol. 4, No. 3 , Pages 343-357).

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 
  • 3 mins

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.

Cortechs.ai | Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®
  • < 1 mins

07/28/2025

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

A case study with Dr. Suzie Bash on NeuroQuant as a reliable, reimbursable, and efficient tool in the evaluation and follow-up of TBI.

Cortechs.ai | Understanding the Hippocampal Occupancy Score
  • 3 mins

07/24/2025

Understanding the Hippocampal Occupancy Score

One of the most frequently asked questions among customers is, “What does the Hippocampal Occupancy Score (HOC) represent within the Dementia Report?”

Cortechs.ai | Advancing Prostate MRI with Restriction Spectrum Imaging
  • 2 mins

07/16/2025

Advancing Prostate MRI with Restriction Spectrum Imaging

Why is OnQ Prostate unique, and what makes it a game-changer for clinicians?

Cortechs.ai | Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT
  • 3 mins

07/08/2025

Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT

Time-sensitive and precise diagnostic imaging can mean the difference between rapid intervention and devastating outcomes.

Cortechs.ai | When to repeat an MRI scan for NeuroQuant<sup>®</sup>
  • 2 mins

07/07/2025

When to repeat an MRI scan for NeuroQuant®

NeuroQuant® can process an array of exams. However, there are some circumstances that will require you to repeat a scan.

View our insights
Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Biomarkers for the clinical evaluation of cognitive impairment
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top